欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CY/H/0107/001
药品名称Zoledronic acid Seacross
活性成分
    • zoledronic acid 5.0 mg/100 ml
剂型Solution for infusion
上市许可持有人SEACROSS PHARMA (EUROPE) LIMITED REGUS DUBLIN AIRPORT, SKYBRIDGE HOUSE, DUBLIN, Ireland
参考成员国 - 产品名称Cyprus (CY)
ZOLEDRONIC ACID SEACROSS SOLUTION FOR INFUSION 0.05MG/ML
互认成员国 - 产品名称
    许可日期2013/06/10
    最近更新日期2024/07/28
    药物ATC编码
      • M05BA08 zoledronic acid
    申请类型
    • TypeLevel1:[not specified]
    • TypeLevel2:[not specified]
    • TypeLevel3:[not specified]
    • TypeLevel4:[not specified]
    • TypeLevel5:[not specified]
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase